MGIA
ONC

Moneta Group Investment Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Moneta Group Investment Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
815
-492
-38% -$145K ﹤0.01% 782
2026
Q1 		$388K Buy
+1,307
New +$423K ﹤0.01% 568

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Moneta Group Investment Advisors's ONC Position: Q2 2026 in Review

Moneta Group Investment Advisors reduced its BeOne Medicines Ltd (ONC) stake by 38% in Q2 2026, selling an estimated $145K and leaving 815 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Moneta Group Investment Advisors first reported a position in ONC in Q1 2026 and has held it in 2 quarters since. The position peaked at $388K in Q1 2026. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Moneta Group Investment Advisors held 815 shares of BeOne Medicines Ltd worth $232K as of Q2 2026.
  • Moneta Group Investment Advisors sold 492 BeOne Medicines Ltd shares in Q2 2026, an estimated $145K.
  • BeOne Medicines Ltd made up ﹤0.01% of Moneta Group Investment Advisors's portfolio in Q2 2026, its #782 holding.
  • Moneta Group Investment Advisors first reported a position in BeOne Medicines Ltd in Q1 2026 and has held it in 2 quarters since.
  • Moneta Group Investment Advisors's BeOne Medicines Ltd position peaked at $388K in Q1 2026.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.